BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25710480)

  • 1. Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.
    Romanets-Korbut O; Najakshin AM; Yurchenko M; Malysheva TA; Kovalevska L; Shlapatska LM; Zozulya YA; Taranin AV; Horvat B; Sidorenko SP
    PLoS One; 2015; 10(2):e0118302. PubMed ID: 25710480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
    Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
    Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotton rat (Sigmodon hispidus) signaling lymphocyte activation molecule (CD150) is an entry receptor for measles virus.
    Carsillo T; Huey D; Levinsky A; Obojes K; Schneider-Schaulies J; Niewiesk S
    PLoS One; 2014; 9(10):e110120. PubMed ID: 25295727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
    Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
    Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells.
    Wang N; Morra M; Wu C; Gullo C; Howie D; Coyle T; Engel P; Terhorst C
    Immunogenetics; 2001 Jul; 53(5):382-94. PubMed ID: 11486275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
    Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
    PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLAMF1/CD150 expression and topology in prostate and breast cancer cell lines.
    Gordiienko IM; Lykhova OO; Shcherbina VM; Shlapatska LM
    Exp Oncol; 2021 Dec; 43(4):312-316. PubMed ID: 34967540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein.
    Welstead GG; Hsu EC; Iorio C; Bolotin S; Richardson CD
    J Virol; 2004 Sep; 78(18):9666-74. PubMed ID: 15331699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstream open reading frames regulate translation of the long isoform of SLAMF1 mRNA that encodes costimulatory receptor CD150.
    Putlyaeva LV; Schwartz AM; Korneev KV; Covic M; Uroshlev LA; Makeev VY; Dmitriev SE; Kuprash DV
    Biochemistry (Mosc); 2014 Dec; 79(12):1405-11. PubMed ID: 25716736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
    Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
    Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection.
    Ohno S; Ono N; Seki F; Takeda M; Kura S; Tsuzuki T; Yanagi Y
    J Virol; 2007 Feb; 81(4):1650-9. PubMed ID: 17135325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
    Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
    Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors.
    Tovar V; del Valle J; Zapater N; Martin M; Romero X; Pizcueta P; Bosch J; Terhorst C; Engel P
    Immunogenetics; 2002 Sep; 54(6):394-402. PubMed ID: 12242590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD150-mediated Akt signalling pathway in normal and malignant B cells.
    Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
    Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
    Yurchenko MY; Kovalevska LM; Shlapatska LM; Berdova GG; Clark EA; Sidorenko SP
    Immunol Cell Biol; 2010 Jul; 88(5):565-74. PubMed ID: 20231852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150).
    Ferreira CS; Frenzke M; Leonard VH; Welstead GG; Richardson CD; Cattaneo R
    J Virol; 2010 Mar; 84(6):3033-42. PubMed ID: 20042501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration.
    Condack C; Grivel JC; Devaux P; Margolis L; Cattaneo R
    J Infect Dis; 2007 Aug; 196(4):541-9. PubMed ID: 17624839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150).
    Navaratnarajah CK; Vongpunsawad S; Oezguen N; Stehle T; Braun W; Hashiguchi T; Maenaka K; Yanagi Y; Cattaneo R
    J Biol Chem; 2008 Apr; 283(17):11763-71. PubMed ID: 18292085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?
    Gordiienko I; Shlapatska L; Kovalevska L; Sidorenko SP
    Clin Immunol; 2019 Jul; 204():14-22. PubMed ID: 30616923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques.
    de Swart RL; Ludlow M; de Witte L; Yanagi Y; van Amerongen G; McQuaid S; Yüksel S; Geijtenbeek TB; Duprex WP; Osterhaus AD
    PLoS Pathog; 2007 Nov; 3(11):e178. PubMed ID: 18020706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.